ATE173613T1 - Behälter, der ein hydrophober arzneimittel enthält - Google Patents

Behälter, der ein hydrophober arzneimittel enthält

Info

Publication number
ATE173613T1
ATE173613T1 AT94926618T AT94926618T ATE173613T1 AT E173613 T1 ATE173613 T1 AT E173613T1 AT 94926618 T AT94926618 T AT 94926618T AT 94926618 T AT94926618 T AT 94926618T AT E173613 T1 ATE173613 T1 AT E173613T1
Authority
AT
Austria
Prior art keywords
active agent
formulation
hydrophobic
delivery device
fluid
Prior art date
Application number
AT94926618T
Other languages
English (en)
Inventor
Liang C Dong
Steven D Espinal
Patrick S-L Wong
George V Guittard
Lawrence G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE173613T1 publication Critical patent/ATE173613T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Packages (AREA)
AT94926618T 1993-08-31 1994-08-31 Behälter, der ein hydrophober arzneimittel enthält ATE173613T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11457393A 1993-08-31 1993-08-31

Publications (1)

Publication Number Publication Date
ATE173613T1 true ATE173613T1 (de) 1998-12-15

Family

ID=22356090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94926618T ATE173613T1 (de) 1993-08-31 1994-08-31 Behälter, der ein hydrophober arzneimittel enthält

Country Status (10)

Country Link
EP (1) EP0716595B1 (de)
JP (1) JP4015184B2 (de)
AT (1) ATE173613T1 (de)
AU (1) AU7640294A (de)
CA (1) CA2165190C (de)
DE (1) DE69414863T2 (de)
DK (1) DK0716595T3 (de)
ES (1) ES2124910T3 (de)
WO (1) WO1995006460A1 (de)
ZA (1) ZA946663B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE69928815T2 (de) * 1998-09-09 2006-06-29 Alza Corp., Mountain View Dosierungsform mit flüssiger formulierung
DE69930952T2 (de) * 1998-11-02 2006-08-31 Alza Corp., Mountain View Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür
JP2002528486A (ja) * 1998-11-02 2002-09-03 アルザ・コーポレーション 有効物質の送達制御
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US9173847B2 (en) 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
JP5069001B2 (ja) 2003-10-10 2012-11-07 ベロクシス ファーマシューティカルズ エー／エス フィブラートを含む固体投与形態
AU2004308973A1 (en) * 2003-12-23 2005-07-14 Alza Corporation Methods and dosage forms for increasing solubility of drug compositions for controlled delivery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192550A (en) * 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders

Also Published As

Publication number Publication date
DE69414863T2 (de) 1999-04-22
JP4015184B2 (ja) 2007-11-28
EP0716595B1 (de) 1998-11-25
WO1995006460A1 (en) 1995-03-09
DE69414863D1 (de) 1999-01-07
DK0716595T3 (da) 1999-08-09
ZA946663B (en) 1995-03-31
ES2124910T3 (es) 1999-02-16
CA2165190A1 (en) 1995-03-09
JPH09502182A (ja) 1997-03-04
AU7640294A (en) 1995-03-22
CA2165190C (en) 2005-07-12
EP0716595A1 (de) 1996-06-19

Similar Documents

Publication Publication Date Title
CA2286482A1 (en) Nkt cell-activating agents containing .alpha.-glycosylceramides
FR2688422B1 (de)
PT96337A (pt) Dispositivo distribuidor de longa duracao incluindo uma dose de carregamento
IL101241A (en) Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
ATE173613T1 (de) Behälter, der ein hydrophober arzneimittel enthält
ATE56358T1 (de) Chlorfluorkohlenstoff-treibstoffaerosolpr|parate, die arzneimittel enthalten.
FI924419A (fi) Ett osmotiskt doseringssystem foer frigoerande av laekemedel i vaetskeform
ES2077971T3 (es) Formulaciones medicinales en aerosol.
DE69535127D1 (de) Emulgierte arzneistoffabgabesysteme
ATE112159T1 (de) Osmotische vorrichtung für verzögerte freisetzung eines wirkstoffes.
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
ATE106015T1 (de) Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
BG103221A (en) Pharmaceutical composition in aerosol form
TR199500826A2 (tr) Multipl ünite tablet doz formu 2.
EP0389177A3 (de) Pharmazeutische Formulierung
EP0537165A4 (de) Polymeres arzneimittelausgabesystem.
BR9916830A (pt) Formulações aerossóis farmacêuticas contendo fluoroalcanos e budesonide
AU621763B2 (en) Stable tretinoin emulsified cream formulations
DE59306211D1 (de) Diphosphonsäuren und deren salze enthaltende arzneimittel
ES2165498T3 (es) Dispositivo osmotico con carga elevada de farmaco y activacion retardada de administracion de farmaco.
PL310530A1 (en) Floor cleaning agent
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
GR3022920T3 (en) Device for defence against insects.
CA2224565A1 (en) Agent for combating parasites in farmed fish
GB2323532B (en) Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee